Navigation Links
ProCure Signs Agreement with .decimal, Inc. to Purchase Patient-Specific Devices for Its Proton Therapy Center in Oklahoma City
Date:2/3/2009

SANFORD, Fla., Feb. 3 /PRNewswire/ -- .decimal, Inc. announced today that it has signed an agreement with ProCure Treatment Centers, Inc. to supply patient-specific devices for its proton therapy facility in Oklahoma City, Oklahoma.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090203/CLTU104LOGO )

".decimal is excited to have a formal agreement signed with ProCure to be their preferred outsource provider of custom, patient-specific devices utilizing our patented, internet-based manufacturing solution," says Richard Sweat, CEO and President of .decimal.

This agreement calls for proton range compensators and apertures to be manufactured in Sanford, Florida and shipped to the facility in Oklahoma within 24-72 hours. Mark Mills, Senior Vice President of Sales and Marketing for .decimal says, "Signing with ProCure just further strengthens the commitment we have made to the proton therapy industry and specifically to their state-of-the-art facility in Oklahoma City."

.decimal, Inc. has been supplying patient-specific medical devices, as well as other custom machining projects for the University of Florida Proton Therapy Institute since June of 2007. This partnership continues to demonstrate why .decimal, Inc. is the industry leader in partnering with proton therapy facilities worldwide.

"We are proud to partner with ProCure as they roll out proton therapy around the world," says Sweat.

As well as working with proton facilities, .decimal, Inc. supplies close to 200 radiation oncology facilities nationwide with patient-specific devices used in Compensator-Based Intensity Modulated Radiation Therapy (IMRT), including 21st Century Oncology sites and H. Lee Moffitt Cancer and Research Center.

With the addition of the facility in Oklahoma, .decimal will continue to develop new and innovative technologies which will increase patient throughput while providing high quality devices to the patients in Oklahoma City.

.decimal is a medical device manufacturer of patient-specific devices, including missing tissue compensators, modulators for advanced Compensator-Based IMRT delivery, as well as apertures and range compensators used in proton therapy. The company has been providing radiation therapy products for over twenty years. For more information concerning .decimal, please see its Web site at www.dotdecimal.com.


'/>"/>
SOURCE .decimal, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PharmAthene Response to DHHS Request for Proposals for Recombinant Protective Antigen Anthrax Vaccine Deemed Technically Acceptable and Within Competitive Range for Procurement Consideration
2. SciQuest Announces Newest Life Sciences Customer; BioMarin Pharmaceutical Drives Spending Effectiveness with Automated, Intuitive Procurement
3. Array BioPharma Selects SciQuest to Automate Procurement and Enable Agile Drug Development
4. ProCure Selects IMPAC as Provider of Oncology Information Systems
5. SciQuest Continues to Surpass Milestones for Customer Wins, Growth and Market Share; Remains Clear Eprocurement Leader for Academic and Research-Centric Organizations
6. AmSurg Selects SciQuest Eprocurement Solution to Automate Purchasing of Medical Goods and Services
7. Signalife Continues to Procure Purchase Orders, Revenues
8. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
9. Traditional Risk Factors Often Miss Heart Disease Warning Signs
10. Sigma-Aldrich Signs Agreement With CPC Scientific for the Distribution of PEPscreen(R) Custom Peptide Libraries
11. Encorium Group Signs $3.1 Million of New Business Contracts Including an Extension of a Current U.S. Oncology Clinical Trial with a Major Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is pleased ... received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of ... Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
Breaking Biology Technology:
(Date:6/9/2016)... , June 9, 2016  Perkotek an innovation leader in attendance control systems ... seamlessly log work hours, for employers to make sure the right employees are actually ... http://photos.prnewswire.com/prnh/20160609/377486LOGO ... ... ...
(Date:6/2/2016)... -- The Department of Transport Management (DOTM) of ... US Dollar project, for the , Supply and ... and IT Infrastructure , to Decatur ... of Identity Management Solutions. Numerous renowned international vendors participated in ... was selected for the most compliant and innovative solution. ...
(Date:5/24/2016)... superior patient care by providing unparalleled technology to leaders of the medical imaging industry. ... recently added to the range of products distributed by Ampronix. Photo - ... ... ... ...
Breaking Biology News(10 mins):